TY  - JOUR

T1  - LBA28 STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC)

JO  - Annals of Oncology

PY  - 2021/09/01

AU  - Brown JE

AU  - Royle K-L

AU  - Ralph C

AU  - Meads D

AU  - Martin A

AU  - Howard H

AU  - Linsley C

AU  - Swain J

AU  - Powles TB

AU  - Jones R

AU  - Eisen T et al

ED  - 

DO  - DOI: 10.1016/j.annonc.2021.08.2104

PB  - Elsevier BV

VL  - 32

SP  - S1303

EP  - S1304

Y2  - 2024/12/21

ER  -